Vanguard Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-8,989,968
| Closed | -$152M | – | 4211 |
|
|
2014
Q4 | $152M | Buy |
8,989,968
+3,370,205
| +60% | +$57.1M | 0.01% | 1135 |
|
|
2014
Q3 | $67M | Buy |
5,619,763
+1,037,202
| +23% | +$12.4M | 0.01% | 1633 |
|
|
2014
Q2 | $25.8M | Sell |
4,582,561
-86,068
| -2% | -$485K | ﹤0.01% | 2120 |
|
|
2014
Q1 | $17.1M | Buy |
4,668,629
+324,799
| +7% | +$1.19M | ﹤0.01% | 2245 |
|
|
2013
Q4 | $14.6M | Buy |
4,343,830
+134,173
| +3% | +$451K | ﹤0.01% | 2298 |
|
|
2013
Q3 | $17.8M | Buy |
4,209,657
+94,285
| +2% | +$400K | ﹤0.01% | 2153 |
|
|
2013
Q2 | $18.9M | Buy |
+4,115,372
| New | +$18.9M | ﹤0.01% | 2088 |
|